SHALAKA AKOLKAR

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology DALTON, GA NPI 1255869863

General Payments — all program years on this page

$921.03

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 36
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $417.68 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $417.6822

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $105.331
2021 $80.492
2022 $201.564
2023 $115.977
2024 $417.6822

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078534830 Janssen Biotech, Inc. $14.80 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078535285 Janssen Biotech, Inc. $14.90 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078535379 Janssen Biotech, Inc. $13.75 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091985693 Ipsen Biopharmaceuticals, Inc $16.60 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091985695 Ipsen Biopharmaceuticals, Inc $29.09 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092397926 Boston Scientific Corporation $28.69 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101088745 Celgene Corporation $19.81 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103191798 ABBVIE INC. $13.08 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103191800 ABBVIE INC. $23.80 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103191802 ABBVIE INC. $15.77 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103191804 ABBVIE INC. $20.95 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103191806 ABBVIE INC. $20.04 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113642673 Intercept Pharmaceuticals, Inc. $22.72 10/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127778449 EVOKE PHARMA, INC. $13.07 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131682378 PFIZER INC. $18.92 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131860535 PFIZER INC. $13.37 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137465328 Takeda Pharmaceuticals U.S.A., Inc. $22.16 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137465333 Takeda Pharmaceuticals U.S.A., Inc. $19.71 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139964605 GENZYME CORPORATION $20.16 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146971629 AIMMUNE THERAPEUTICS, INC. $15.34 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147001111 AIMMUNE THERAPEUTICS, INC. $21.08 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153577090 Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.87 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.